POSEIDA THERAPEUTICS, INC.

PSTX NASDAQ
0.0000
0.00%
休市 09:30 07/19 EDT
开盘
--
昨收
--
最高
--
最低
--
成交量
--
成交均量(3M)
--
52周最高
--
52周最低
--
换手率
0%
市值
--
分时
5日
1月
3月
1年
5年

相关股票

微牛行情栏目提供POSEIDA THERAPEUTICS, INC. PSTX股票价格,POSEIDA THERAPEUTICS, INC.股票实时行情,公司简介,财报信息,股本结构等,掌握美港股行情走势,开盘价,收盘价,总市值,换手率,市盈率,收益率等数据,及时把握美股港股投资机会。

公司介绍

Poseida Therapeutics, Inc. is a clinical-stage biopharmaceutical company that develops gene engineering technologies to create therapeutics for patients with unmet medical need. The Company has built a pipeline of autologous and allogeneic chimeric antigen receptor thymus (T) cell product candidates, which is focused on the treatment of hematological malignancies and solid tumors. Its P- bone marrow cell maturation antigen (BCMA)-101 is an autologous chimeric antigen receptor (CAR)-T therapy being developed to treat patients with relapsed or refractory multiple myeloma. P-PSMA-101 is an autologous CAR-T product candidate that enables treatment of patients with castrate-resistant prostate cancer (CRPC). P-BCMA-ALLO1 is an allogeneic CAR-T product candidate using cells derived from a donor as starting material that enables treatment of patients with multiple myeloma from a single manufacturing run.
展开 >

最近浏览

名称
价格
涨跌幅